SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network Inc. ($BNAI) is experiencing a parabolic surge, fueled by its recent Valio Technologies deal and AI initiatives, alongside an extremely low share float and high short interest leading to soaring borrow rates. The trading community is intensely focused on a massive short squeeze, drawing parallels to previous extreme volatility events and speculating on triple-digit price targets. This intense interest has positioned $BNAI as a highly speculative play within the broader AI microcap sector.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth (USAR) is trending due to significant government and private investment aimed at bolstering domestic rare earth production. The community is actively debating the impact of the multi-billion dollar funding on the company's valuation, with many anticipating a substantial surge and a short squeeze. This move is broadly seen as a strategic play to secure critical minerals and reduce reliance on foreign supply chains.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust ($SLV) is experiencing a parabolic surge, shattering past price levels and fueling intense bullish sentiment across the community. Many are calling it unstoppable, driven by concerns over currency devaluation and robust industrial demand, while bears anticipate a significant profit-taking pullback or rotation to other commodities. The ongoing discussion highlights a major short squeeze and a re-evaluation of silver's intrinsic value amidst broader market shifts.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending due to its Breakthrough Therapy Designation for pemvidutide in MASH, which has amplified discussions around its best-in-class potential in the rapidly growing MASH and obesity markets. The community is largely bullish, anticipating a significant strategic partnership or acquisition given the drug's dual-action benefits and favorable safety profile. However, some market participants remain cautious, citing concerns about past trial data and potential market manipulation influencing recent price action.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is trending sharply after reporting promising interim Phase 1 data for its obesity candidate, WVE-007, which demonstrated visceral fat reduction and muscle preservation, a key differentiator from current GLP-1 therapies. The financial community is actively debating its potential to revolutionize obesity treatment with less frequent dosing and an improved side effect profile, fueling intense speculation about the company's appeal as an acquisition target for major pharmaceutical firms.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending as gold prices reach unprecedented levels, with community discussion centered on its role as a premier safe haven asset amid heightened global geopolitical tensions and concerns over currency stability. Many investors are celebrating significant gains and anticipating further upside, while some caution about an overextended market and the potential for a sharp correction. This rally is widely perceived as a flight to quality, driven by central bank diversification and a diminishing trust in traditional financial assets.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

Q/C Technologies (QCLS) is drawing significant attention following the strategic appointment of an OpenAI expert to its board and a completed certification process, signaling a strong pivot into AI and quantum-class computing. The community is actively discussing the stock's high volatility and potential for substantial gains, frequently comparing it to recent explosive movers, with some highlighting ambitious price targets and others noting dilution concerns. This focus on cutting-edge technology and new leadership is driving considerable speculative interest among traders.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

The SPDR Dow Jones Industrial Average ETF is trending as renewed geopolitical tensions, primarily driven by tariff threats concerning Greenland, have spurred significant market volatility and a notable sell-off. Community discussions reflect a tug-of-war between those anticipating a "buy the dip" opportunity and others expressing concern over potential broader market instability from escalating trade conflicts and underlying Japanese bond market stress. This environment highlights how political rhetoric and international relations are actively shaping investor sentiment and market direction.

Urban One, Inc. is a multi-media company, which engages in radio broadcasting that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, Cable Television, and All Other-Corporate and Eliminations. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the results of operations for the related activities and operations of the company’s syndicated shows. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One and CLEO TV operations. The company was founded by Catherine L. Hughes in 1980 and is headquartered in Silver Spring, MD.

Urban One Inc - Ordinary Shares - Class A

Urban One Inc

Urban One Inc. is trending following its 1-for-10 reverse stock split which became effective on January 23, 2026, prompting immediate market attention. The community is actively discussing the stock's post-split price action and watching for sustained volume to determine if this move will generate further momentum for the media company.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is a major talking point in the biotech sector, driven by recent clinical data showcasing an an 81% disease control rate in advanced pancreatic cancer using its Alpha DaRT technology. The community is highly anticipating an imminent PMDA approval in Japan and is closely watching for further developments from its FDA submissions, with increasing institutional interest noted.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of NeueHealth Inc. skyrocketed over 64% in premarket trading Tuesday, heading toward highs last seen in March, following the announcement of a $1.3 billion take-private deal by an affiliate of New Enterprise Associates (NEA).Under the agreement, NeueHealth shareholders will receive $7.33 per share in cash, representing a 70% premium to the stock’s closing price on Monday.&nbsp;The transaction values the company at approximately $1.3 billion on an enterprise basis.NeueHealth’s executive team will retain their roles and roll over their equity interests into the privately held entity.&nbsp;President and CEO Mike Mikan said, “We are pleased to announce this transaction as we believe it places NeueHealth in a strong position for continued growth while maximizing value for all of NeueHealth's public stockholders.”NEA’s Co-CEO Mohamad Makhzoumi praised NeueHealth’s differentiated care model, citing its ability to create value for consumers, providers, and payors.&nbsp;NEA has been a strategic partner of NeueHealth since 2016, according to the company.NeueHealth operates across the Bright HealthCare and NeueHealth segments, focusing on value-based care through Medicare Advantage and individual and family health plans.<figure class="image"><img style="aspect-ratio:1318/324;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/NEUE_sentiment_and_message_volume_Dec_24_premarket_eb2132dc2b.png" alt="NEUE sentiment and message volume Dec 24 premarket.png" width="1318" height="324"><figcaption>NEUE sentiment and message volume Dec 24 premarket as of 9:10 am ET | source: Stocktwits</figcaption></figure>On Stocktwits, sentiment turned ‘extremely bullish,’ with message volume hitting its highest level of the year.&nbsp;<stembedurl>https://stocktwits.com/TAE63/message/597705834</stembedurl><stembedurl>https://stocktwits.com/Broncos07/message/597713880</stembedurl><a href="https://stocktwits.com/symbol/NEUE">NeueHealth shares</a> are down over 41% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

NeueHealth Stock Soars Toward 9-Month Highs On $1.3B Take-Private Deal: Retail Exuberant

Under the agreement, NeueHealth shareholders will receive $7.33 per share in cash, representing a 70% premium to the stock’s closing price on Monday. 

Equity

NeueHealth, Inc. engages in the provision of healthcare products and services for consumers and care providers in local markets. The firm offers individual, family, and Medicare advantage health plans. It operates through the NeueCare and NeueSolutions segments. The NeueCare segment delivers healthcare to all populations across the ACA marketplace, Medicare, and Medicaid through owned and affiliated clinics. The NeueSolutions segment provides a suite of technology, services, and clinical care solutions. The company was founded by Robert J. Sheehy, Tomas Valdivia, and Kyle Rolfing in 2015 and is headquartered in Doral, FL.

NeueHealth Inc.

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$0.80	--	--	N/A
Q2 '25	-$0.11	-$1.68	-1427.27%	MISSED
Q1 '25	-$2.20	-$1.80	18.18%	BEAT
Q4 '24	-$4.18	-$7.41	-77.06%	MISSED
Q3 '24	-$2.92	-$6.78	-132.00%	MISSED

NEUE
NeueHealth Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest NEUE News

NEUENeueHealth Inc.